|
Curran M. Simpson joined HGS in March 2003 as Vice President Manufacturing Operations. He was promoted to Senior Vice President Operations in December 2005. Prior to joining HGS Mr. Simpson was Director of Manufacturing Sciences at Biogen's North Carolina facility. In this role he led the technology transfer start-up and validation activities for Biogen's large-scale manufacturing facility and completed a successful pre-approval inspection (PAI) resulting in commercialization of Amevive. Previous to his position with Biogen Mr. Simpson held process development and manufacturing positions with several biotechnology companies including Genencor Genentech Novo-Nordisk ( U.S. and Europe) and Covance. Mr. Simpson has been involved in the scale-up and manufacturing operations for a number of commercial products including Pulmozyme TNKase Herceptin and Retavase. Mr. Simpson earned his M.S. degree in Surface and Colloid Science (Physical Chemistry) from Clarkson University and his B.S. degree in Chemical Engineering/Chemistry from the Clarkson College of Technology. | 